Article info
Review
Comparative effectiveness and harms of intravitreal antivascular endothelial growth factor agents for three retinal conditions: a systematic review and meta-analysis
- Correspondence to Allison Low, Evidence-based Synthesis Program, VA Portland Health Care System, Portland, OR 97239, USA; low{at}oakland.edu
Citation
Comparative effectiveness and harms of intravitreal antivascular endothelial growth factor agents for three retinal conditions: a systematic review and meta-analysis
Publication history
- Received June 7, 2018
- Revised September 27, 2018
- Accepted October 23, 2018
- First published November 8, 2018.
Online issue publication
March 22, 2019
Article Versions
- Previous version (8 November 2018).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.